Dangerous Drug: Tamoxifen Citrate



Dangerous Drug: Tamoxifen Citrate





(ta mox’ i fen)

Apo-Tamox (CAN), Gen-Tamoxifen (CAN), Soltamox, Tamofen (CAN)

PREGNANCY CATEGORY D


Drug Classes

Antiestrogen

Antineoplastic


Therapeutic Actions

Potent antiestrogenic effects: Competes with estrogen for binding sites in target tissues, such as the breast.


Indications



  • Treatment of metastatic breast cancer in women and men; in premenopausal women with metastatic breast cancer, tamoxifen is an alternative to oophorectomy or ovarian irradiation


  • Treatment of node-positive breast cancer in postmenopausal women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation


  • Treatment of axillary node-negative breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation


  • Reduction in risk of invasive breast cancer in women with ductal carcinoma in situ (DCIS) following breast surgery and radiation


  • Reduction in occurrence of contralateral breast cancer in patients receiving adjuvant tamoxifen therapy for breast cancer


  • Reduction in incidence of breast cancer in women at high risk for breast cancer


  • Unlabeled uses: Treatment of mastalgia; useful for decreasing size and pain of gynecomastia; treatment of McCune-Albright syndrome and precocious puberty in girls 2–10 yr; malignant carcinoid tumor, carcinoid syndrome; menstrual migraine; oligospermia; metastatic melanoma desmoid tumors



Available Forms

Tablets—10, 20 mg; oral solution—10 mg/5 mL


Dosages

Adults

Jul 21, 2016 | Posted by in NURSING | Comments Off on Dangerous Drug: Tamoxifen Citrate

Full access? Get Clinical Tree

Get Clinical Tree app for offline access